An International Multi-Centre Randomised Adaptive Platform Clinical Trial to Assess the
Clinical, Virological and Immunological Outcomes in Patients with SARS-CoV-2 Infection
(COVID-19).
Phase:
Phase 3
Details
Lead Sponsor:
University of Melbourne
Collaborators:
Australasian Society for Infectious Diseases Hunter Medical Research Institute Middlemore Clinical Trials The George Institute The Peter Doherty Institute for Infection and Immunity The University of Queensland